MSN laboratories collaborates with BITS Pilani WILP to elevate educational opportunities for their…
The collaboration aims to help their professionals keep pace with the rapid global pharmaceutical industry evolution and in…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
MSN Laboratories
MSN Laboratories launches Posaconazole to treat mucormycosis
MSN has launched the product under the brand name PosaOne as 100 mg Delayed-Release tablets and 300 mg injections, respectively
Lilly signs licensing agreements with Dr Reddy’s, MSN Labs and Torrent Pharma for Baricitinib
On May 10, Lilly had also announced the signing of three Voluntary License Agreements with Cipla, Lupin and Sun Pharma Industries
MSN Laboratories launches Favilow (Faripiravir) 800 mg tablets
The higher strength Favilow 800 mg is priced at Rs 144 per tablet and will be available across pharmacies
MSN Laboratories to launch favipiravir at Rs 33
The company will be launching it on August 15 under the brand name Favilow
FDA grants approvals for generic Lyrica
The FDA granted approvals for the generic versions of Lyrica to Alembic Pharmaceuticals, Alkem Laboratories, Amneal…
Panel discussion: Bridging the gap between exhibit batches and day-to-day manufacturing
FDD Conclave 2019 focussed on the theme, 'Preparing for the next frontiers in FDD'. And, a great deal of being future-ready…